Our μPharma paper is out in @MedCellPress! 🧬
We combined digital microfluidics + machine learning to predict T-ALL drug sensitivity from pretreatment biomarkers—no multi-day drug incubation needed.https://t.co/5HKe02s4Ib
Holiday fun in the lab! 🎄🏠 Our interdisciplinary team from @UtahBME and @PHCEUutah joined forces for a festive gingerbread house-making activity. A sweet way to celebrate the holiday season and our collaborative spirit! #LabLife#HappyHolidays
We are hiring postdoctoral scholars! Join us to explore exciting new research on how environment exposures impact health using extracellular vesicle analysis. #postdoc#hiring#research#innovation https://t.co/8corWkWMI6
Yue Lu, PhD, is turning bold ideas into reality with a New Innovator Award from NIH's High-Risk, High-Reward Research program! This honor supports groundbreaking work with the potential for major societal impact. @PHCEUutah@UofUHealth@uofupharmacy
https://t.co/HjBnFXXKnR
Congratulations to Dr. Yue Lu @rincewind_LU for receiving the 2024 #NIHHighRisk New Innovator Award—we are very grateful for the support of @NIH_CommonFund ! https://t.co/TX40YXBy1a
Dr. Yue Lu of @UofUHealth has received the #NIHHighRisk New Innovator Award for her research on extracellular vesicles that will help us better understand how our environment impacts our body and health. Learn more: https://t.co/dbdzs1Z6Gr
A new #COVID19 pub from @UUtah researchers! Check it out: Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2 https://t.co/jrpebxJNzp @UofUResearch
Congratulations to Dr. Alphonsus Ng (Biomedical Engineering), Huiqian Hu (Molecular Pharmacetuics Ph.D student), and Dr. Yue Lu (Molecular Pharmaceutics) for their new paper in Cell Reports! @DigiPharmaLab
https://t.co/1vfgN2RMkQ
When you have #COVID19, #SARSCoV2 spreads throughout the body. But why are the lungs hit hardest? Mucosal lymphoid tissues might be the key. Learn about our findings and the analytical framework that could aid in future COVID studies and more. https://t.co/6In3ucVgMd